Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery

British Journal of Anaesthesia

Volumn 100, Issue 4, 2008, Pages 442-450

  Zuurbier, C J ^a   Hoek, F J ^a   Van Dijk, J ^a   Abeling, N G ^a   Meijers, J C M ^a   Levels, J H M ^a   De Jonge, E ^a   De Mol, B A ^a   Van Wezel, H B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Metabolism, insulin; Metabolism, lipid; Surgery, cardiovascular; Surgery, metabolic response

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DOBUTAMINE; FATTY ACID; GLUCOSE; HEPARIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETONE BODY; LACTIC ACID; LOW DENSITY LIPOPROTEIN; MORPHINE; NEUTRAL INSULIN; NITRIC ACID DERIVATIVE; PANCURONIUM BROMIDE; POTASSIUM CHLORIDE; PROPOFOL; PROTAMINE SULFATE; SUFENTANIL CITRATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN; LIPOPROTEIN TRIGLYCERIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPOLIPEMIA; LIPID ANALYSIS; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DYSLIPIDEMIA; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; METABOLISM; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; INSULIN; KETONE BODIES; LACTIC ACID; LIPOPROTEINS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TRIGLYCERIDES;

EID: 41949124671     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen018     Document Type: Article

References (38)

1. Apstein CS, Opie LH. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 2005; 26: 956-9
2. Lopaschuk GD, Collins-Nakai R, Olley PM, et al. Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 1994; 128: 61-7
3. Oliver MF, Kurien VZ, Greenwood TN. Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1968; 1: 710-5
4. Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000; 101: 2090-6
5. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999; 99: 578-88
6. Opie LH. The glucose hypothesis: relation to acute myocardial ischaemia. J Mol Cell Cardiol 1970; 1: 107-14
7. Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T. Maintenance of normoglycemia during cardiac surgery. Anesth Analg 2004; 99: 319-24
8. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 104: 1497-502
9. Van den Berghe G, Wouters R, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67
10. Visser L, Zuurbier CJ, Hoek FJ, et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 2005; 95: 448-57
11. Tian R, Balschi JA. Interaction of insulin and AMPK in the ischemic heart. Another chapter in the book of metabolic therapy. Circ Res 2006; 99: 3-5
12. Tuunanen H, Engblom E, Naum A, et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 2006; 114: 2130-7
13. Pietersen HG, Langenberg CJM, Geskes G, et al. Myocardial substrate uptake and oxidation during and after routine cardiac surgery. J Thorac Cardiovasc Surg 1999; 118: 71-80
14. Krebs M, Stingl H, Nowotny P, et al. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 2000; 46: 950-4
15. Goodwin GW, Taegtmeyer H. Improved energy homeostasis of the heart in the metabolic state of exercise. Am J Physiol Heart Circ Physiol 2000; 279: H1490-501
16. Lloyd S, Brocks C, Chatham JC. Differential modulation of glucose, lactate and pyruvate oxidation by insulin and dichloro-acetate in the isolated perfused rat heart. Am J Physiol Heart Circ Physiol 2003; 285: H163-72
17. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostag Leukotr Essent Fatty Acids 2004; 70: 309-19
18. Van Wezel HB, Zuurbier CJ, de Jonge E, et al. Differential effects of a perioperative hyperinsulinemic normoglycemic clamp on the neurohumoral stress response during coronary artery surgery. J Clin Endocrinol Metab 2006; 91: 4144-53
19. Sodi-Pallares D, Testelli MR, Fishleder BL. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962; 9: 166-81
20. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96: 1152-6
21. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80: 3A-10A
22. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437-46
23. Timmer JR, Svilaas T, Ottervanger JP, et al. Glucose-insulin- potassium infusion in patients with acute myocardial infarction without signs of heart failure: the glucose-insulin-potassium study (GIPS)-II. J Am Coll Cardiol 2006; 47: 1730-1
24. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trail. Cardiovasc Drugs Ther 1999; 13: 191-200
25. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med 2007; 146: 233-43
26. Mueller HS, Ayres SM. Metabolic responses of the heart in acute myocardial infarction in man. Am J Cardiol 1978; 42: 363-71
27. Svensson S, Svedjeholm R, Ekroth R, et al. Trauma metabolism and the heart. Uptake of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg 1990; 99: 1063-73
28. Smith A, Grattan A, Harper M, Royston D, Riedel BJ. Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study. J Cardiothorac Vasc Anesth 2002; 16: 413-20
29. Kashyap SR, Belfort R, Berria R, et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes. Am J Physiol Endocrin Metab 2007; 287: E537-46
30. Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med 2006; 34: 2974-8 31 Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lip Res 1994; 35: 177-93
31. Stanley AW, Moraski RE, Russel RO, et al. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Am J Cardiol 1975; 36: 929-37
32. Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, Allard MF. Regulation of myocardial fatty acid oxidation by substrate supply. Am J Physiol Heart Circ Physiol 2001; 281: H1561-7
33. Niu YG, Hauton D, Evans RD. Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates. J Physiol 2004; 558: 225-37
34. Augustus AS, Buchanan J, Park TS, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 2006; 281: 8716-23
35. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-7
36. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thor Cardiovasc Surg 2006; 131: 34-42
37. Bruemmer-Smith S, Avidan MS, Harris B, et al. Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesth 2002; 88: 489-95
38. Szabo Z, Hakanson E, Jorfeldt L, Svedjeholm R. Myocardial uptake and release of substrates in type II diabetics undergoing coronary surgery. Scand Cardiovasc J 2001; 35: 207-11